Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
British Journal of Clinical Pharmacology|October 19, 2013
Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate hepatic impairmentKarthik Venkatakrishnan, Yi Liu, Dennis Noe, et al.
Journal of Clinical Pharmacology|June 27, 2014
Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal functionPing He, Doug Kerr, Thomas Marbury, et al.
Thrombosis and Haemostasis|January 9, 2015
Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysisDolly A Parasrampuria, Thomas Marbury, Nobujo Matsushima, et al.
Thrombosis and Haemostasis|September 22, 2017
Pharmacokinetics of Tecarfarin and Warfarin in Patients with Severe Chronic Kidney DiseaseDetlef Albrecht, Mintu P Turakhia, Daniel Ries, et al.
Clinical Pharmacology in Drug Development|May 20, 2020
Pharmacokinetics of Gepotidacin in Renal ImpairmentMohammad Hossain, Courtney Tiffany, Aparna Raychaudhuri, et al.
Clinical and Translational Science|August 9, 2023
A phase I, open-label, single-dose study to evaluate the effect of hepatic impairment on the pharmacokinetics and safety of futibatinibLing Gao, Ikuo Yamamiya, Mark Pinti, et al.
American Journal of Therapeutics|July 8, 2003
Effects of renal insufficiency and hemodialysis on the pharmacokinetics of rofecoxibKeith Gottesdiener, Nancy Agrawal, Arturo Porras, et al.
Clinical Pharmacokinetics|April 6, 2019
Pharmacokinetics of the BCL-2 Inhibitor Venetoclax in Subjects with Hepatic ImpairmentAhmed Hamed Salem, Nimita Dave, Thomas Marbury, et al.
Clinical Pharmacokinetics|July 18, 2012
Single-dose pharmacokinetics of boceprevir in subjects with impaired hepatic or renal functionMichelle Treitel, Thomas Marbury, Richard A Preston, et al.
Journal of Clinical Pharmacology|September 5, 2014
Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta-1a in subjects with normal or impaired renal functionXiao Hu, Ali Seddighzadeh, Scott Stecher, et al.
Pageof 8